[1] Parkinson’s disease: Mechanisms and models. Neuron, 39, 889-909(2003).
[2] Fluorescent probes for bioimaging of potential biomarkers in Parkinson’s disease. Chem. Soc. Rev., 50, 1219-1250(2021).
[3] A review of quality of life after predictive testing for and earlier identification of neurodegenerative diseases. Prog. Neurobiol., 110, 2-28(2013).
[4] Parkinson disease. Nat. Rev. Dis. Primers, 3, 17013(2017).
[5] Understanding the molecular causes of Parkinson’s disease. Trends Mol. Med., 12, 521-528(2006).
[6] Diagnosis and treatment of Parkinson disease: A review. JAMA, 323, 548-560(2020).
[7] Parkinson’s disease. Med. Clin. North Am., 103, 337-350(2019).
[8] An update on medical and surgical treatments of parkinson’s disease. Aging Dis, 12, 1021-1035(2021).
[9] The sources of reactive oxygen species and its possible role in the pathogenesis of Parkinson’s disease. Parkinson’s Dis., 2018, 9163040(2018).
[10] The role of oxidative stress in Parkinson’s disease. Antioxidants, 9, 597(2020).
[11] Rational design of nanocarriers for mitochondria-targeted drug delivery. Chin. Chem. Lett., 33, 4146-4156(2022).
[12] Neurodegenerative diseases and oxidative stress. Nat. Rev. Drug Discov., 3, 205-214(2004).
[13] Recent advances and perspectives in reaction-based fluorescent probes for imaging peroxynitrite in biological systems. Coord. Chem. Rev., 474, 214848(2023).
[14] Activity-based fluorescence probes for pathophysiological peroxynitrite fluxes. Coord. Chem. Rev., 454, 214356(2022).
[15] G1-4A, a polysaccharide from tinospora cordifolia induces peroxynitrite dependent killer dendritic cell (KDC) activity against tumor cells. Int. Immunopharmacol., 23, 480-488(2014).
[16] When it comes to an end: Oxidative stress crosstalk with protein aggregation and neuroinflammation induce neurodegeneration. Antioxidants, 9, 740(2020).
[17] A near-infrared fluorescent probe for ratiometric imaging peroxynitrite in Parkinson’s disease model. Sens. Actuators B, Chem., 359, 131393(2022).
[18] Ultrafast detection of peroxynitrite in Parkinson’s disease models using a near-infrared fluorescent probe. Anal. Chem., 92, 4038-4045(2020).
[19] Reaction-based luminescent probes for reactive sulfur, oxygen, and nitrogen species: Analytical techniques and recent progress. Anal. Chem., 92, 309-326(2020).
[20] Water-soluble cationic boronate probe based on coumarin imidazolium scaffold: Synthesis, characterization, and application to cellular peroxynitrite detection. Free Radic. Biol. Med., 179, 34-46(2022).
[21] New strategies for fluorescent probe design in medical diagnostic imaging. Chem. Rev., 110, 2620-2640(2010).
[22] An inherently kidney-targeting near-infrared fluorophore based probe for early detection of acute kidney injury. Biosens. Bioelectron., 172, 112756(2021).
[23] Multifunctional nanotheranostics for near infrared optical imaging-guided treatment of brain tumors. Adv. Drug Deliv. Rev., 190, 114536(2022).
[24] Recent advances in small molecular near-infrared fluorescence probes for a targeted diagnosis of the Alzheimer disease. Analyst, 147, 4701-4723(2022).
[26] Four-armed functional siloxane enables ratiometric unconventional fluorescence for the detection of ONOO−. Sens. Actuat. B. Chem., 331, 129462(2021).
[27] An ICT-based fluorescent probe for ratiometric monitoring the fluctuations of peroxynitrite in mitochondria. Sens. Actuators B, Chem., 328, 129069(2021).
[28] A novel highly selective fluorescent probe with new chalcone fluorophore for monitoring and imaging endogenous peroxynitrite in living cells and drug-damaged liver tissue. Talanta, 215, 120934(2020).
[29] Investigation of drug-induced hepatotoxicity and its remediation pathway with reaction-based fluorescent probes. Anal. Chem., 89, 7693-7700(2017).
[30] Two-photon fluorescent probe for revealing drug-induced hepatotoxicity via mapping fluctuation of peroxynitrite. Chem. Sci., 8, 4006-4011(2017).
[31] Rational design of an α-ketoamide-based near-infrared fluorescent probe specific for hydrogen peroxide in living systems. Anal. Chem., 88, 8019-8025(2016).
[32] Construction of a novel far-red fluorescence light-up probe for visualizing intracellular peroxynitrite. Talanta, 197, 431-435(2019).
[33] A sensitive two-photon probe to selectively detect monoamine oxidase B activity in Parkinson’s disease models. Nat. Commun., 5, 3276(2014).
[34] A two-photon fluorescent probe for visualizing endoplasmic reticulum peroxynitrite in Parkinson’s disease models. Sens. Actuators B, Chem., 328, 129003(2021).
[35] Two-photon dual-channel fluorogenic probe for in situ imaging the mitochondrial H2S/viscosity in the brain of drosophila Parkinson’s disease model. Chin. Chem. Lett., 31, 2903-2908(2020).
[36] A targetable fluorescent probe for imaging hydrogen peroxide in the mitochondria of living cells. J. Am. Chem. Soc., 130, 9638-9639(2008).
[37] A novel fluorogenic probe for visualizing the hydrogen peroxide in Parkinson’s disease models. J. Innov. Opt. Health Sci., 13, 2050013(2020).
[38] A novel pyrimidine based deep-red fluorogenic probe for detecting hydrogen peroxide in Parkinson’s disease models. Talanta, 199, 628-633(2019).
[39] A mitochondria-targeted two-photon fluorogenic probe for the dual-imaging of viscosity and H2O2 levels in Parkinson’s disease models. J. Mater. Chem. B, 7, 4243-4251(2019).
[40] A fast detection of peroxynitrite in living cells. Anal. Chim. Acta, 1106, 96-102(2020).
[41] Direct oxidation of boronates by peroxynitrite: Mechanism and implications in fluorescence imaging of peroxynitrite. Free Rad. Biol. Med., 47, 1401-1407(2009).
[42] Reversible near-infrared fluorescent probe introducing tellurium to mimetic glutathione peroxidase for monitoring the redox cycles between peroxynitrite and glutathione in vivo. J. Am. Chem. Soc., 135, 7674-7680(2013).
[43] A near-IR reversible fluorescent probe modulated by selenium for monitoring peroxynitrite and imaging in living cells. J. Am. Chem. Soc., 133, 11030-11033(2011).
[44] α-synuclein amplifies cytoplasmic peroxide flux, oxidative stress provoked by mitochondrial inhibitors in CNS dopaminergic neurons in vivo. Redox Biol., 37, 101695(2020).
